MicroRNAs (miRNAs) are a fascinating potential factor for ME/CFS because they are malleable; i.e they can change over time, and they affect gene expression. That gives them the power to biologically rewrite who we are. While they can’t change our underlying DNA...
Researchers in both fibromyalgia (FM) and chronic fatigue syndrome (ME/CFS) are doing deeper dives into the genetics of these illnesses than have ever been done before and they’re coming up with some surprises. Travis Craddock of the Institute for Neuroimmune...
“Barely slept last night after we announced funding for a £3.2m DNA study partnership that I Chair. Seven years+ of advocacy and lobbying final paid off.” Sonya Chowdhury, CEO of Action for ME – a leader in the effort When the Brits do it, sometimes...
EpicGenetics – a biotech firm in Los Angeles – is attempting an FM trifecta: produce a blood and genomic test and provide a treatment. EpicGenetics is trying to make a big splash in fibromyalgia. A Los Angeles biotech firm, they focused on producing...
Solve ME funds seven pilot studies on chronic fatigue syndrome (ME/CFS) in its 2019 Ramsay Awards The great thing about Solve ME’s Ramsay awards is their sheer breadth. Particularly with the 2019 awards, the Ramsays are dropping seeds across the biological...
A recent Klimas/Broderick study had a lot of interesting things in it: the gender divide, and the illumination of possibly key immune and metabolic factors, but the most intriguing thing about the study was its potential precision. The study possibly identified...